Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

RWJ-63556: dual COX-2/5-LO inhibitor effective in canine model of local inflammation

Sep. 12, 1997

IDEC licenses rights to novel antiinflammatory technology

Sep. 11, 1997

New hydroxamic acid compounds inhibiting TNF, PDE IV and/or MMPs

Sep. 11, 1997

Promising preliminary results obtained with Arthrovas in osteoarthritis

Sep. 10, 1997

Boehringer Mannheim prepares MMP inhibitors

Sep. 8, 1997

Anika completes phase III trial on Orthovisc

Sep. 4, 1997

New MMP and TNF inhibitor from Kanebo

Sep. 2, 1997

Hyalgan introduced in U.S. for osteoarthritis of the knee

Sep. 1, 1997

Pharos receives patent for novel method of controlling and treating inflammation

Aug. 29, 1997

Stromelysin inhibitors: New approach to treating arthritis?

Aug. 29, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...